Eli Lilly’s migraine treatment wins U.S. FDA approval

The U.S. Food and Drug Administration said on Friday it had approved Eli Lilly and Co’s migraine drug, Reyvow.


Read More

Uncategorized

Leave a Reply and send us your feed back

This site uses Akismet to reduce spam. Learn how your comment data is processed.